Complete Filing Data
Evogene Ltd. reported Cash And Cash Equivalents of $12.96 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Evogene Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $4.3M | $7.0M | $5.4M | $6.5M | $7.3M | $5.3M | $3.8M | $3.5M | $3.8M | $3.9M | $4.4M |
| Research And Development Expense | $8.0M | $12.5M | $16.2M | $20.8M | $21.1M | $17.3M | $15.8M | $14.7M | $17.0M | $16.4M | $14.4M |
| Profit Loss From Operating Activities | -$14.0M | -$18.8M | -$22.2M | -$26.9M | -$31.0M | -$24.8M | -$21.2M | -$20.0M | -$21.9M | -$21.1M | -$17.9M |
| Profit Loss Before Tax | -$13.5M | -$14.8M | -$21.9M | -$29.8M | -$30.4M | -$26.2M | -$19.1M | -$20.8M | -$20.8M | -$19.6M | -$17.2M |
| Profit Loss | -$7.8M | -$18.1M | -$26.0M | -$29.8M | -$30.4M | -$26.2M | -$19.1M | -$20.8M | -$20.8M | -$19.6M | -$17.2M |
| Gross Profit | -$241.0K | $3.2M | $1.5M | $766.0K | $163.0K | $466.0K | $419.0K | $295.0K | $536.0K | $901.0K | $2.9M |
| Cost Of Sales | $4.1M | $2.4M | $1.5M | $909.0K | $767.0K | $574.0K | $334.0K | $1.5M | $2.8M | $5.6M | $8.3M |
| Adjustments For Reconcile Profit Loss | $3.2M | -$945.0K | $1.9M | $7.0M | $4.1M | $8.1M | $2.0M | $4.5M | $2.9M | $3.6M | $6.0M |
| Income Taxes Paid Classified As Operating Activities | $11.0K | $11.0K | $31.0K | $40.0K | $13.0K | $13.0K | $24.0K | $23.0K | $14.0K | $6.0K | |
| Income Tax Expense Continuing Operations | $1.0K | $9.0K | $19.0K | $90.0K | $13.0K | $32.0K | $24.0K | $30.0K | $11.0K | $36.0K | |
| Adjustments For Income Tax Expense | -$6.0K | $9.0K | -$33.0K | $90.0K | $13.0K | $32.0K | $24.0K | $30.0K | $11.0K | $36.0K | |
| Profit Loss Attributable To Owners Of Parent | -$8.5M | -$16.5M | -$23.9M | -$26.6M | -$27.8M | -$23.4M | -$18.1M | -$20.8M | -$20.8M | -$19.6M | |
| Profit Loss Attributable To Noncontrolling Interests | $658.0K | -$1.6M | -$2.1M | -$3.2M | -$2.7M | -$2.8M | -$1.0M | -$54.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $13.0M | $15.3M | $20.8M | $29.0M | $32.3M | $46.2M | $34.7M | $5.8M | $3.4M | $3.2M | $10.2M | $5.2M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $135.0K | $626.0K | $577.0K | $1.2M | $847.0K | $682.0K | $900.0K | $374.0K | $590.0K | $808.0K | $2.0M | |
| Cash Flows From Used In Operating Activities | -$13.5M | -$19.7M | -$21.6M | -$23.7M | -$24.7M | -$19.5M | -$17.7M | -$15.2M | -$15.9M | -$11.7M | -$12.4M | |
| Cash Flows From Used In Investing Activities | $17.7M | $9.6M | -$4.5M | $13.3M | -$20.6M | $9.4M | $37.1M | $17.4M | $15.2M | $4.0M | $17.4M | |
| Cash Flows From Used In Financing Activities | -$6.6M | $4.7M | $18.2M | $9.3M | $30.3M | $20.4M | $9.3M | $297.0K | $814.0K | $655.0K | $45.0K | |
| Adjustments For Increase Decrease In Trade Account Payable | -$259.0K | -$630.0K | $757.0K | -$469.0K | $625.0K | -$29.0K | -$122.0K | -$114.0K | -$86.0K | -$215.0K | -$68.0K | |
| Adjustments For Increase Decrease In Other Operating Payables | -$570.0K | $222.0K | -$515.0K | $48.0K | $290.0K | -$87.0K | $375.0K | $20.0K | $145.0K | -$298.0K | -$640.0K | |
| Adjustments For Decrease Increase In Trade Account Receivable | $665.0K | -$627.0K | -$7.0K | -$67.0K | -$59.0K | -$150.0K | $88.0K | -$28.0K | $37.0K | $2.5M | -$1.5M | |
| Adjustments For Decrease Increase In Other Operating Receivables | $1.0M | $806.0K | -$1.2M | $1.1M | $637.0K | -$1.3M | -$1.3M | $95.0K | $221.0K | -$100.0K | -$293.0K | |
| Adjustment For Increase Decrease In Changes In Asset And Liability Items | -$1.3M | -$2.6M | -$278.0K | -$771.0K | $1.7M | -$1.4M | -$997.0K | -$161.0K | -$196.0K | $1.9M | -$3.8M | |
| Acquisition Of Property Plant And Equipment | $2.0K | $120.0K | $81.0K | $74.0K | $32.0K | $57.0K | $216.0K | $80.0K | $39.0K | $150.0K | $349.0K | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -$756.0K | -$548.0K | $532.0K | -$675.0K | $127.0K | $456.0K | -$33.0K | $31.0K | -$7.0K | $5.0K | -$3.0K | |
| Purchase Of Marketable Securities | $0.00 | $0.00 | $503.0K | $911.0K | $23.1M | $0.00 | $1.6M | $31.7M | $11.7M | $24.6M | $31.2M | |
| Retained Earnings | -$282.6M | -$274.1M | -$257.6M | -$233.7M | -$207.1M | -$179.3M | -$155.9M | -$137.8M | -$117.0M | -$96.2M | ||
| Property Plant And Equipment | $812.0K | $1.8M | $2.5M | $2.5M | $2.1M | $2.1M | $2.6M | $3.2M | $4.8M | $6.5M | ||
| Other Current Receivables | $1.6M | $2.1M | $3.0M | $1.5M | $2.7M | $3.4M | $2.1M | $861.0K | $904.0K | $1.2M | ||
| Other Current Payables | $449.0K | $1.1M | $1.0M | $1.6M | $1.5M | $1.2M | $1.3M | $935.0K | $2.9M | $2.8M | ||
| Noncurrent Liabilities | $4.6M | $6.3M | $15.5M | $15.7M | $6.0M | $5.4M | $5.4M | $3.0M | $3.6M | $3.5M | ||
| Noncurrent Assets | $4.4M | $18.3M | $16.6M | $18.4M | $19.4M | $20.1M | $22.3M | $3.2M | $4.8M | $6.5M | ||
| Equity Attributable To Owners Of Parent | -$82.0K | -$1.5M | $12.1M | $27.9M | $53.7M | $46.0M | $50.1M | $50.1M | $69.4M | $87.3M | $103.8M | |
| Equity And Liabilities | $20.0M | $39.9M | $51.1M | $56.1M | $76.3M | $71.9M | $71.4M | $58.7M | $77.6M | $96.0M | ||
| Current Trade Receivables | $317.0K | $1.1M | $357.0K | $348.0K | $281.0K | $222.0K | $72.0K | $160.0K | $132.0K | $169.0K | ||
| Current Liabilities | $3.4M | $18.7M | $6.9M | $5.6M | $6.9M | $9.7M | $5.7M | $5.4M | $4.7M | $5.2M | ||
| Current Assets | $15.6M | $21.6M | $34.5M | $37.8M | $56.9M | $51.8M | $49.0M | $55.5M | $72.8M | $89.5M | ||
| Assets | $20.0M | $39.9M | $51.1M | $56.1M | $76.3M | $71.9M | $71.4M | $58.7M | $77.6M | $96.0M | ||
| Shortterm Deposits Not Classified As Cash Equivalents | $10.0K | $10.3M | $0.00 | $3.0M | $2.0M | $10.0M | $22.6M | $8.4M | $13.1M | |||
| Rightofuse Assets | $1.8M | $2.4M | $980.0K | $1.6M | $2.1M | $1.9M | $2.7M | |||||
| Noncurrent Lease Liabilities | $1.5M | $1.9M | $285.0K | $932.0K | $1.7M | $1.7M | $2.1M | |||||
| Intangible Assets Other Than Goodwill | $0.00 | $12.2M | $13.2M | $14.1M | $15.2M | $16.1M | $17.1M | |||||
| Current Lease Liabilities | $716.0K | $589.0K | $853.0K | $884.0K | $974.0K | $777.0K | $895.0K | |||||
| Trade And Other Current Payables | $639.0K | $1.2M | $1.8M | $1.0M | $1.5M | $863.0K | $1.0M | $1.0M | $1.1M | $1.3M | ||
| Amortisation Intangible Assets Other Than Goodwill | $974.0K | $971.0K | $1.1M | $932.0K | $935.0K | $374.0K | ||||||
| Adjustments For Gain Loss On Disposals Property Plant And Equipment | $209.0K | -$525.0K | $26.0K | $0.00 | -$121.0K | $0.00 | -$12.0K | -$39.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | -$2.3M | -$5.5M | -$8.2M | -$3.3M | -$13.9M | $11.5M | $28.9M | $2.4M | $199.0K | -$7.0M | $5.0M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $21.0K | -$49.0K | -$245.0K | -$2.3M | $1.1M | $1.2M | $159.0K | -$114.0K | $69.0K | $25.0K | -$17.0K |
| Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method | $0.00 | $0.00 | $6.9M | $12.4M | $4.4M | $2.1M | $27.1M | $63.6M | $22.7M | $23.9M | $38.2M |
| Proceeds From Government Grants Classified As Financing Activities | $0.00 | $134.0K | $1.0M | $149.0K | $824.0K | $320.0K | $493.0K | $354.0K | $339.0K | $802.0K | $167.0K |
| Proceeds From Issue Of Ordinary Shares | 4.3M | 123.0K | 8.4M | 21.0K | 29.6M | 18.7M | 0.00 | ||||
| Payments Of Lease Liabilities Classified As Financing Activities | $526.0K | $886.0K | $675.0K | $803.0K | $580.0K | $639.0K | $597.0K | ||||
| Proceeds From Exercise Of Options | $0.00 | $0.00 | $7.0K | $484.0K | $59.0K | $0.00 | $9.0K | $683.0K | $186.0K | $296.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Number Of Shares Issued | 8.7M | 6.5M | 5.1M | 41.3M | 41.2M | 380.4K | 25.8M | 25.8M | 25.8M | 25.5M |
| Par Value Per Share | $0.20 | $0.20 | $0.20 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 |
| Weighted Average Shares | 7.9M | 5.7M | 4.6M | 4.1M | 40.4M | 28.2M | 25.8M | 25.8M | 25.7M | 25.4M |
| Number Of Shares Outstanding | 8.7M | 6.5M | 5.1M | 41.3M | 41.2M | 35.6M | 25.8M | 25.8M | 25.8M | 25.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Repayment Of Government Grants Classified As Financing Activities | $244.0K | $298.0K | $73.0K | $31.0K | $34.0K | $22.0K | $590.0K | $66.0K | $208.0K | $333.0K | $418.0K |
| Operating Expense | $13.8M | $22.0M | $23.7M | $27.7M | $31.1M | $25.3M | $21.6M | $20.3M | $22.5M | $22.0M | $20.8M |
| Interest Received Classified As Operating Activities | $338.0K | $934.0K | $905.0K | $186.0K | $297.0K | $294.0K | $803.0K | $1.4M | $2.2M | $2.4M | $2.7M |
| Finance Income | $2.5M | $7.4M | $1.2M | $516.0K | $1.9M | $1.6M | $2.6M | $1.4M | $2.1M | $2.4M | $2.6M |
| Finance Costs | $1.9M | $3.4M | $928.0K | $3.3M | $1.4M | $3.0M | $555.0K | $2.2M | $1.0M | $891.0K | $1.9M |
| Adjustments For Sharebased Payments | $654.0K | $1.2M | $1.1M | $1.2M | $2.6M | $4.1M | $1.6M | $1.7M | $2.2M | $2.9M | $4.4M |
| Adjustments For Depreciation And Amortisation Expense | $1.1M | $1.4M | $1.3M | $1.5M | $1.3M | $1.8M | $2.4M | $2.0M | $2.1M | $2.3M | $2.4M |
| Adjustments For Finance Income Cost | $28.0K | $771.0K | $661.0K | -$3.0M | $884.0K | -$967.0K | $2.4M | -$746.0K | $1.5M | ||
| Issued Capital | $488.0K | $363.0K | $286.0K | $235.0K | $234.0K | $200.0K | $142.0K | $142.0K | $142.0K | $141.0K | |
| Noncurrent Government Grants | $3.1M | $4.3M | $4.4M | $4.7M | $4.3M | $3.7M | $3.3M | $2.9M | $3.4M | $3.3M | |
| Interest Paid Classified As Operating Activities | $193.0K | $67.0K | $121.0K | $165.0K | $315.0K | $238.0K | $302.0K | ||||
| Current Government Grants | $56.0K | $323.0K | $388.0K | $79.0K | $89.0K | $72.0K | $37.0K | $988.0K | $104.0K | $125.0K | |
| Number Of Shares Authorised | 30.0M | 15.0M | 15.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | |
| Capital Reserve | $282.0M | $272.3M | $269.4M | $261.4M | $260.5M | $225.1M | $205.9M | $187.7M | $186.3M | $183.3M | |
| Noncontrolling Interests | $12.1M | $16.3M | $16.6M | $6.9M | $9.8M | $10.8M | $10.1M | $253.0K | |||
| Increase Decrease Through Sharebased Payment Transactions | $292.0K | $1.8M | $1.9M | $4.1M | $1.6M | $1.7M | $2.2M | $2.9M | $4.4M | ||
| Current Provisions For Employee Benefits | $861.0K | $1.9M | $2.5M | $2.0M | $2.7M | $2.5M | $2.1M | $2.1M | |||
| Finance Income Expense Net | -$2.8M | $521.0K | -$1.4M | $2.1M | -$793.0K | $1.1M | $1.5M | ||||
| Adjustments For Decrease Increase In Inventories | -$1.0M | -$1.3M | $489.0K | -$474.0K | -$92.0K | $0.00 | $0.00 | ||||
| Longterm Deposits | $74.0K | $25.0K | $9.0K | $9.0K | $19.0K | $19.0K | $13.0K | ||||
| Increase Decrease Through Exercise Of Options | $7.0K | $427.0K | $107.0K | $9.0K | $683.0K | $186.0K | $296.0K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.